Effects of simvastatin in abdominal sepsis in rats<A NAME="volta1"></A>

Abstract

Purpose: Statins are widely recognized as hypolipemic drugs, but some studies have observed anti-inflammatory and immunomodulatory effects, known as pleiotropic. The aims of this work was to study possible anti-inflammatory effects of simvastatin in abdominal sepsis. Serum pro-inflammatory cytokines and leukocytes count were determined in an experimental model of abdominal sepsis, using cecal ligation and puncture (CLP) in rats. Methods: Twenty eigth Wistar rats weighing 285±12g were randomly divided in: CLP/Sinvastatin rats (n=7), treated with 10 mg/Kg of oral simvastatin 18 and 2 hs berofe CLP; CLP/Saline group rats (n=7), treated with oral saline; group Sham/Simvastatin (n=7), treated with simvastatin, and group Sham/Saline (n=7), treated with saline. Serum TNF-α, IL-1β and IL-6 by ELISA and total leukocytes, neutrophils, lymphocytes, and eosinophils were determined 24 hs after CLP. ANOVA and Tukey test were used considering significant p<0.05. Results: It was demonstrated that serum TNF-α, IL-1β and IL-6 were respectively 364,8±42pg/mL; 46,3±18pg/mL and 28,4±13pg/mL in CLP/Sinvastatin rats, significantly lower (p<0.05) than in group CLP/Saline (778,5±86pg/ml; 176,9±46pg/ ml; 133,6±21 pg/ml, respectively). The same results were observed in total leukocytes and neutrophils counts. Conclusion: These results clearly demonstrate that simvastatin is an effective agent that reduces cytokines levels and leukocyte count in sepsis, independently of its well-known lipid-lowering effects. Thus, HMG-CoA reductase inhibitors like simvastatin have important anti-inflammatory effects in abdominal sepsis in rats. Key words: Statin. Inflammation. Abdominal sepsis. Wistar rat. Cytokine. Leukocyte. RESUMO Objetivo:As estatinas são agentes reconhecidamente hipolipemiantes. Vários estudos têm revelado que eles têm ações pleiotrópicas, como antiinflamatória e imunomoduladora. Tentando-se entender o papel antiinflamatório da sinvastatina na sepse, foram analisados os níveis de citocinas pró-inflamatórias e contagem de leucócitos em modelo de sepse abdominal por ligadura e punção do ceco (LPC) em ratos. Métodos: Foram utilizados 28 ratos Wistar pesando 285±12g, assim divididos: grupo sepse (n=14), submetidos a LPC e grupo sham (n=14), submetidos a laparotomia e manipulação suave do ceco. No grupo LPC/sinvastatina (n=7) os ratos receberam 10mg/kg de sinvastatina via oral 18 e 2 horas antes da LPC e no grupo LPC/salina (n=7) os ratos receberam injeção oral de solução salina 0,9 %. Os animais dos grupos sham/sinvastatina (n=7) e sham/salina (n=7) receberam o mesmo tratamento. Dosagem de TNF-α, IL-1β e IL-6 por ELISA e contagem de leucócitos totais, neutrófilos, linfócitos e eosinófilos foram realizadas em todos os animais. Análise estatística foi feita pelo ANOVA e teste de Tukey, com significância p<0,05. Resultados: Ficou demonstrado que as dosagens de TNF-α, IL-1β e IL-6 atingiram valores de 364,8±42pg/ml; 46,3±18pg/ml e 28,4±13pg/ml no grupo submetido à sepse e tratados com sinvastatina, significantemente mais baixos do que...

Heart and systemic effects of statin pretreatment in a rat model of abdominal sepsis. Assessment by Tc99m-sestamibi biodistribition

“…The results showed that TNF-α, IL-1β and IL-6 values in septic group previously treated with simvastatin were significantly lower than in the untreated sepsis group. The same occurred in total leukocytes and neutrophils 14 . In another study, our group showed that simvastatin also had important anti-inflammatory action in the abdominal sepsis in diabetic rats.…”

Protective effect of simvastatin in the cyclophosphamide-induced hemohrragic cystitis in rats

“…It has been also demonstrated that statin decreases the expression of cytokines 26 . Moreover, recent experimental studies have demonstrated the antiinflammatory action of statins in improving the healing of infected wounds in rats 6 , as well as in abdominal sepsis 7 .…”

“…Statins have been shown to be especially effective in reducing low-density lipoprotein cholesterol (LDL) and, to a lesser extent, triglyceride levels 2 . Statins' antiinflammatory effects have been proposed not only to reduce cardiovascular disease, but also to help improve other conditions that are not influenced by lipid levels, including rheumatoid arthritis 3 , stroke 4 , graft rejection 5 and infection 6,7 .…”

Therapeutic effects of simvastatin combined with kallistatin treatment for pediatric burn patients with sepsis

“…It has been reported that simvastatin increases the survival of patients with sepsis or infection by inhibiting sepsis-induced mortality and preventing acute kidney injury (12). It has also been demonstrated that induces anti-inflammatory effects in abdominal sepsis (13). Furthermore, simvastatin treatment improves the survival rate in a murine model of burn sepsis by elevating interleukin (IL)-6 levels (14).…”